Profile

Sonya Heltshe, PhD

Sonya Heltshe, PhD

Children's Title: Senior Biostatistician

Academic Title: Assistant Professor

Research Center: Center for Clinical and Translational Research

Overview

Medical/Professional School

National Cancer Institute, Bethesda
University of Colorado Denver , Aurora

Research Description

Biostatistics, clinical trials, and translational research in Cystic Fibrosis and Pulmonology

Publications

  • Heltshe SL | Goss CH | Thompson V | Sagel SD | Sanders DB | Marshall BC | Flume PA
    Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
    Thorax , 2015 Apr, 24
  • Muhlebach MS | Heltshe SL | Popowitch EB | Miller MB | Thompson V | Kloster M | Ferkol T | Hoover WC | Schechter MS | Saiman L | the STAR-CF Study Team
    Multicenter Observational Study on Factors and Outcomes Associated with Different MRSA Types in Children with Cystic Fibrosis.
    Annals of the American Thoracic Society , 2015 Mar. 6
  • Heltshe SL, Mayer-Hamblett N, Burns JL, Khan U, Baines A, Ramsey BW, Rowe SM, GOAL (the G551D Observation-AL) Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network
    Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , 2015 Mar. 1 : 60(5)703-12
  • Rowe SM | Heltshe SL | Gonska T | Donaldson SH | Borowitz D | Gelfond D | Sagel SD | Khan U | Mayer-Hamblett N | Van Dalfsen JM | Joseloff E | Ramsey BW | GOAL Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network
    Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.
    American journal of respiratory and critical care medicine , 2014 July 15 : 190(2)175-84
  • DeBoer EM, Swiercz W, Heltshe SL, Anthony MM, Szefler P, Klein R, Strain J, Brody AS, Sagel SD
    Automated CT scan scores of bronchiectasis and air trapping in cystic fibrosis.
    Chest , 2014 Mar. 1 : 145(3)593-603
  • Heltshe SL, Khan U, Barbieri JT, Langkamp M, Döring G, Dharia S, Gibson RL, Treggiari MM, Lymp J, Rosenfeld M, Ramsey B
    Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial.
    Journal of Cystic Fibrosis , 2012 Aug.

Research Funding

Grant Title Grantor Amount Award Date
Cell Phone Spirometry Pilot in CF Patients Coulter Foundation July 1, 2012
Translational Research Center to Expedite Novel Therapies in Cystic Fibrosis (P30) NIH/NIDDK July 6, 2010
Therapeutics Development Network Coordinating Center Cystic Fibrosis Foundation Therapeutics April 1, 2003